1-9 of 9
Keywords: Polymyxin B
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Nephrology
Blood Purif (2025)
Published Online: 11 March 2025
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Hemoadsorption Blood purification Polymyxin B Endotoxic septic shock Extracorporeal blood purification (EBP) is defined...
Journal Articles
Blood Purif (2021) 50 (2): 222–229.
Published Online: 26 November 2020
... patients. [email protected] 16 01 2020 9 07 2020 26 11 2020 Cardiac surgery Pediatric sepsis Polymyxin B Endotoxin Selective PMX hemoperfusion © 2020 S. Karger AG, Basel 2020 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2018) 46 (2): 81–89.
Published Online: 19 April 2018
...Hiroshi Maekawa; Kousuke Negishi Background/Aims: Polymyxin-B (PMX) treatment has been reported to decrease mortality in patients with septic shock and acute kidney injury (AKI). In this study, we aimed to evaluate whether extended sessions of PMX (Ext-PMX) immobilized fiber column hemoperfusion...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2014) 37 (Suppl. 1): 9–13.
Published Online: 20 January 2014
...Dinna N. Cruz Endotoxin, one of the principal components on the outer membrane of Gram-negative bacteria, is considered a key and early component in the pathogenesis of sepsis. Polymyxin B bound to polystyrene fibers (PMX) is a medical device capable of removing circulating endotoxin by adsorption...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2014) 37 (Suppl. 1): 14–17.
Published Online: 20 January 2014
...Debra Foster; David J. Klein; Gualtiero Guadagni; Paul M. Walker The EUPHRATES trial (Evaluating Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock) is the first biomarker-driven trial in sepsis. This unique trial is being run...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2014) 37 (Suppl. 1): 22–25.
Published Online: 20 January 2014
...The Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 (EUPHAS2) Collaborative Group After the publication of the EUPHAS trial, the clinical use of polymyxin B hemoperfusion (Toraymyxin®) increased significantly in Italy. Nevertheless, no structured data collections have been carried...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2014) 37 (Suppl. 1): 18–21.
Published Online: 20 January 2014
... and devices, such as polymyxin B hemoperfusion, must be optimized not only for potential benefits for a specific population (i.e. efficacy), but also for their eventual implementation in real-world situations (i.e. effectiveness) and for economic costs (i.e. efficiency). In this regard, theragnosis and newer...
Journal Articles
Subject Area:
Nephrology
Blood Purif (2012) 33 (4): 252–256.
Published Online: 30 March 2012
... of hemoperfusion with a polymyxin B cartridge (PMX) after the diagnosis of septic shock could improve the clinical outcome. Methods: A prospective, open-labeled, multicenter cohort study was performed at intensive care units in Japan. 41 patients received PMX within 6 h after the diagnosis of septic shock (early...
Journal Articles